» Articles » PMID: 28936969

Systematic Integration of Biomedical Knowledge Prioritizes Drugs for Repurposing

Overview
Journal Elife
Specialty Biology
Date 2017 Sep 23
PMID 28936969
Citations 204
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to computationally predict whether a compound treats a disease would improve the economy and success rate of drug approval. This study describes Project Rephetio to systematically model drug efficacy based on 755 existing treatments. First, we constructed Hetionet (neo4j.het.io), an integrative network encoding knowledge from millions of biomedical studies. Hetionet v1.0 consists of 47,031 nodes of 11 types and 2,250,197 relationships of 24 types. Data were integrated from 29 public resources to connect compounds, diseases, genes, anatomies, pathways, biological processes, molecular functions, cellular components, pharmacologic classes, side effects, and symptoms. Next, we identified network patterns that distinguish treatments from non-treatments. Then, we predicted the probability of treatment for 209,168 compound-disease pairs (het.io/repurpose). Our predictions validated on two external sets of treatment and provided pharmacological insights on epilepsy, suggesting they will help prioritize drug repurposing candidates. This study was entirely open and received realtime feedback from 40 community members.

Citing Articles

MedKG: enabling drug discovery through a unified biomedical knowledge graph.

Kumari M, Chauhan R, Garg P Mol Divers. 2025; .

PMID: 40085402 DOI: 10.1007/s11030-025-11164-z.


Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas construction and usage.

Borner K, Blood P, Silverstein J, Ruffalo M, Satija R, Teichmann S Nat Methods. 2025; .

PMID: 40082611 DOI: 10.1038/s41592-024-02563-5.


Understanding ecological systems using knowledge graphs: an application to highly pathogenic avian influenza.

Robertson H, Han B, Castellanos A, Rosado D, Stott G, Zimmerman R Bioinform Adv. 2025; 5(1):vbaf016.

PMID: 40041112 PMC: 11879169. DOI: 10.1093/bioadv/vbaf016.


Hypothesizing mechanistic links between microbes and disease using knowledge graphs.

Santangelo B, Bada M, Hunter L, Lozupone C Sci Rep. 2025; 15(1):6905.

PMID: 40011529 PMC: 11865272. DOI: 10.1038/s41598-025-91230-6.


ENQUIRE automatically reconstructs, expands, and drives enrichment analysis of gene and Mesh co-occurrence networks from context-specific biomedical literature.

Musella L, Afonso Castro A, Lai X, Widmann M, Vera J PLoS Comput Biol. 2025; 21(2):e1012745.

PMID: 39932993 PMC: 11844901. DOI: 10.1371/journal.pcbi.1012745.


References
1.
Pinero J, Queralt-Rosinach N, Bravo A, Deu-Pons J, Bauer-Mehren A, Baron M . DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (Oxford). 2015; 2015:bav028. PMC: 4397996. DOI: 10.1093/database/bav028. View

2.
Cheng J, Yang L, Kumar V, Agarwal P . Systematic evaluation of connectivity map for disease indications. Genome Med. 2015; 6(12):540. PMC: 4278345. DOI: 10.1186/s13073-014-0095-1. View

3.
Mihalak K, Carroll F, Luetje C . Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006; 70(3):801-5. DOI: 10.1124/mol.106.025130. View

4.
Ashburn T, Thor K . Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004; 3(8):673-83. DOI: 10.1038/nrd1468. View

5.
Beaulieu-Jones B, Greene C . Reproducibility of computational workflows is automated using continuous analysis. Nat Biotechnol. 2017; 35(4):342-346. PMC: 6103790. DOI: 10.1038/nbt.3780. View